Indicated for the treatment of: Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL). Mantle Cell Lymphoma (MCL): For patients who have received at least one prior therapy. Waldenström's Macroglobulinemia (WM).

Dosage and administration

Strength: 140 mg per capsule. Daily Regimen (Once Daily): CLL & Waldenström's: 420 mg = Take 3 capsules daily. Mantle Cell Lymphoma: 560 mg = Take 4 capsules daily. ⚠️ Instructions: Swallow whole with water at the same time each day. Avoid Grapefruit and Seville oranges completely.

Monitor for the following: Bleeding/Bruising: Very common. Report severe bleeding immediately. Diarrhea: Stay hydrated. Cardiac Arrhythmias: Atrial fibrillation (irregular heartbeat) may occur. Musculoskeletal pain and fatigue.

Nitib — Ibrutinib 140 mg, 30 pcs, Hetero

100% original product

Active ingredient

Ibrutinib

Manufacturer

Hetero

Dosage 140 mg

Dosage form Capsules

Capsules per pack 30

Nitib (Ibrutinib) 140 mg

Name: Nitib
Brand: Hetero
SKU: PROD-42
Price: 4527 UAH
Availability: InStock

4527₴ ~~5054₴~~ -10%

Nitib is a breakthrough targeted therapy for B-cell malignancies. Active ingredient: Ibrutinib (140 mg).

Manufacturer: Hetero Healthcare (India). Generic equivalent of Imbruvica.

Mechanism:

Nitib acts as a Bruton's Tyrosine Kinase (BTK) inhibitor. By permanently bonding to the BTK protein, it shuts down the survival signals within malignant B-cells, causing them to die or stop multiplying.

✅ Key Benefit: An oral, chemotherapy-free option that offers long-term disease control.

Indicated for the treatment of:

Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL).
Mantle Cell Lymphoma (MCL): For patients who have received at least one prior therapy.
Waldenström's Macroglobulinemia (WM).

Strength: 140 mg per capsule.

Daily Regimen (Once Daily):

CLL & Waldenström's: 420 mg = Take 3 capsules daily.
Mantle Cell Lymphoma: 560 mg = Take 4 capsules daily.

⚠️ Instructions: Swallow whole with water at the same time each day. Avoid Grapefruit and Seville oranges completely.

🚫 SURGERY WARNING (Bleeding Risk):

Ibrutinib increases the risk of bleeding. Therapy should be interrupted for 3 to 7 days prior to and after any surgery (including dental work), depending on the surgery type and bleeding risk.

Other Contraindications:

Severe hepatic impairment.
Pregnancy and breastfeeding.
Concomitant use of Warfarin (increases hemorrhage risk).

Monitor for the following:

Bleeding/Bruising: Very common. Report severe bleeding immediately.
Diarrhea: Stay hydrated.
Cardiac Arrhythmias: Atrial fibrillation (irregular heartbeat) may occur.
Musculoskeletal pain and fatigue.

Notice. The information on this page is for reference only and does not replace medical consultation. Always consult a healthcare professional and read the manufacturer's instructions before using any medicine. Self-medication may be dangerous. Information updated: 06.04.2026